help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shapiro, D. N.
Right arrow Articles by Look, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shapiro, D. N.
Right arrow Articles by Look, A. T.

American Journal of Pathology, Vol 142, 1339-1346, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma

DN Shapiro, MB Valentine, ST Rowe, AE Sinclair, JE Sublett, WM Roberts and AT Look
Department of Experimental Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105.

We assessed fluorescence in situ hybridization (FISH) as an alternative to Southern blot analysis for determination of N-myc gene amplification in neuroblastoma. In the 44 pediatric solid tumor cell lines examined (20 neuroblastomas), the mean number of N-myc copies determined by FISH correlated closely with Southern blot results. There was wide intercellular variability in gene copy number in tumors that had evidence of amplification; however, tumors judged to be non-amplified completely lacked any cells with high N-myc copy number. FISH provided reliable estimates of N-myc amplification in 12 clinical samples even when the percentage of tumor was low. The other advantages of FISH over Southern blot analysis were speed and technical simplicity, ability to discern heterogeneous gene amplification among tumor cells in the same specimen, and capacity to determine the source of the amplified N-myc signal, whether extrachromosomal double-minute chromosomes, expanded intrachromosomal regions, or chromosome 2 aneuploidy. We conclude that FISH would refine the analysis of N-myc amplification in neuroblastoma and thus improve the assignment of patients to prognostic groups based on this unfavorable risk factor.


This article has been cited by other articles:


Home page
JCOHome page
J. Schneiderman, W. B. London, G. M. Brodeur, R. P. Castleberry, A. T. Look, and S. L. Cohn
Clinical Significance of MYCN Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group
J. Clin. Oncol., February 20, 2008; 26(6): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Haber, J. Smith, S. B. Bordow, C. Flemming, S. L. Cohn, W. B. London, G. M. Marshall, and M. D. Norris
Association of High-Level MRP1 Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma
J. Clin. Oncol., April 1, 2006; 24(10): 1546 - 1553.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. E. George, W. B. London, S. L. Cohn, J. M. Maris, C. Kretschmar, L. Diller, G. M. Brodeur, R. P. Castleberry, and A. T. Look
Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study
J. Clin. Oncol., September 20, 2005; 23(27): 6466 - 6473.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
W.B. London, R.P. Castleberry, K.K. Matthay, A.T. Look, R.C. Seeger, H. Shimada, P. Thorner, G. Brodeur, J.M. Maris, C.P. Reynolds, et al.
Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group
J. Clin. Oncol., September 20, 2005; 23(27): 6459 - 6465.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. S. Kretschmar, M. Kletzel, K. Murray, P. Thorner, V. Joshi, R. Marcus, E. I. Smith, W. B. London, and R. Castleberry
Response to Paclitaxel, Topotecan, and Topotecan-Cyclophosphamide in Children With Untreated Disseminated Neuroblastoma Treated in an Upfront Phase II Investigational Window: A Pediatric Oncology Group Study
J. Clin. Oncol., October 15, 2004; 22(20): 4119 - 4126.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Katzenstein, S. L. Cohn, R. M. Shore, D. M.E. Bardo, P. R. Haut, M. Olszewski, J. Schmoldt, D. Liu, A. W. Rademaker, and M. Kletzel
Scintigraphic Response by 123I-Metaiodobenzylguanidine Scan Correlates With Event-Free Survival in High-Risk Neuroblastoma
J. Clin. Oncol., October 1, 2004; 22(19): 3909 - 3915.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. N. Cook, A. F. Olshan, H. A. Guess, D. A. Savitz, C. Poole, J. Blatt, M. L. Bondy, and B. H. Pollock
Maternal Medication Use and Neuroblastoma in Offspring
Am. J. Epidemiol., April 15, 2004; 159(8): 721 - 731.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Krams, H.-J. Heidebrecht, B. Hero, F. Berthold, D. Harms, R. Parwaresch, and P. Rudolph
repp86 Expression and Outcome in Patients With Neuroblastoma
J. Clin. Oncol., May 1, 2003; 21(9): 1810 - 1818.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Kletzel, H. M. Katzenstein, P. R. Haut, A. L. Yu, E. Morgan, M. Reynolds, G. Geissler, M. H. Marymount, D. Liu, J. A. Kalapurakal, et al.
Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study
J. Clin. Oncol., May 1, 2002; 20(9): 2284 - 2292.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
N Bown
Neuroblastoma tumour genetics: clinical and biological aspects
J. Clin. Pathol., December 1, 2001; 54(12): 897 - 910.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Krams, A. Claviez, K. Heidorn, G. Krupp, R. Parwaresch, D. Harms, and P. Rudolph
Regulation of Telomerase Activity by Alternate Splicing of Human Telomerase Reverse Transcriptase mRNA in a Subset of Neuroblastomas
Am. J. Pathol., November 1, 2001; 159(5): 1925 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. J. De Roos, A. F. Olshan, K. Teschke, C. Poole, D. A. Savitz, J. Blatt, M. L. Bondy, and B. H. Pollock
Parental Occupational Exposures to Chemicals and Incidence of Neuroblastoma in Offspring
Am. J. Epidemiol., July 15, 2001; 154(2): 106 - 114.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Katzenstein, P. M. Kent, W. B. London, and S. L. Cohn
Treatment and Outcome of 83 Children With Intraspinal Neuroblastoma: The Pediatric Oncology Group Experience
J. Clin. Oncol., February 15, 2001; 19(4): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. L. Cohn, W. B. London, D. Huang, H. M. Katzenstein, H. R. Salwen, T. Reinhart, J. Madafiglio, G. M. Marshall, M. D. Norris, and M. Haber
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
J. Clin. Oncol., November 1, 2000; 18(21): 3604 - 3613.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Q. Yang, A. F. Olshan, M. L. Bondy, N. R. Shah, B. H. Pollock, R. C. Seeger, A. T. Look, and S. L. Cohn
Parental Smoking and Alcohol Consumption and Risk of Neuroblastoma
Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 967 - 972.
[Abstract] [Full Text]


Home page
JCOHome page
C. Poremba, C. Scheel, B. Hero, H. Christiansen, K.-L. Schaefer, J.-i. Nakayama, F. Berthold, H. Juergens, W. Boecker, and B. Dockhorn-Dworniczak
Telomerase Activity and Telomerase Subunits Gene Expression Patterns in Neuroblastoma: A Molecular and Immunohistochemical Study Establishing Prognostic Tools for Fresh-Frozen and Paraffin-Embedded Tissues
J. Clin. Oncol., July 1, 2000; 18(13): 2582 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. C. Raggi, M. L. Bagnoni, G. P. Tonini, M. Maggi, G. Vona, P. Pinzani, K. Mazzocco, B. De Bernardi, M. Pazzagli, and C. Orlando
Real-Time Quantitative PCR for the Measurement of MYCN Amplification in Human Neuroblastoma with the TaqMan Detection System
Clin. Chem., November 1, 1999; 45(11): 1918 - 1924.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Yoshimoto, S. R. Caminada de Toledo, E. M. Monteiro Caran, M. T. de Seixas, M. L. de Martino Lee, S. de Campos Vieira Abib, S. M. R. Vianna, S. T. Schettini, and J. Anderson Duffles Andrade
MYCN Gene Amplification : Identification of Cell Populations Containing Double Minutes andHomogeneously Staining Regions in Neuroblastoma Tumors
Am. J. Pathol., November 1, 1999; 155(5): 1439 - 1443.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
B.-F. Chen, M.-L. Chen, D.-C. Liang, H.-C. Liu, and S.-H. Chen
The Relationship of N-myc Amplification and Apoptosis in Neuroblastoma
International Journal of Surgical Pathology, January 1, 1999; 7(1): 19 - 25.
[Abstract] [PDF]


Home page
Genome Res.Home page
R. Gururajan, J. M. Lahti, J. Grenet, J. Easton, I. Gruber, P. F. Ambros, and V. J. Kidd
Duplication of a Genomic Region Containing the Cdc2L1-2 and MMP21-22 Genes on Human Chromosome 1p36.3 and their Linkage to D1Z2
Genome Res., September 1, 1998; 8(9): 929 - 939.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.